Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations

Genetic Epidemiology

Volumn 17, Issue 4, 1999, Pages 298-309

  Harmon, Dawn L ^a   Shields, Denis C ^b   Woodside, Jayne V ^c   McMaster, Dorothy ^c   Yarnell, John W G ^c   Young, Ian S ^c   Peng, Kun ^d   Shane, Barry ^d   Evans, Alun E ^c   Whitehead, Alexander S ^e,f  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cardiovascular disease; Folate; Neural tube defects; Vitamin B12; Vitamin B6

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE SYNTHASE; PYRIDOXINE;

ADULT; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; NEURAL TUBE DEFECT; VITAMIN METABOLISM;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADULT; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PYRIDOXINE; VITAMIN B 12;

EID: 0032713815     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2272(199911)17:4<298::AID-GEPI5>3.0.CO;2-V     Document Type: Article

References (28)

1. Alfthan G, Pekkanen J, Jauhiainen M, Pitkaniemi J, Karvonen M, Tuomilehto J, Salonen JT, Ehnholm C. 1994. Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 106:9-19.
2. Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE. 1995. Serum total homocysteine and coronary heart disease. Int J Epidemiol 24:704-709.
3. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. 1995. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049-1057.
4. Chasan-Taber L, Selhub J, Rosenberg IH, Malinow MR, Terry P, Tishler PV, Willett W, Hennekens CH, Stampfer MJ. 1996. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr 15:136-143.
5. Chen LH, Liu M-L, Hwang H-Y, Chen L-S, Korenberg J, Shane B. 1997. Human methionine synthase: cDNA cloning, gene localization, and expression. J Biol Chem 272:3628-3634.
6. Evans RW, Shaten BJ, Hempel JD, Cutler JA, Kuller LH. 1997. Homocyst(e)ine and risk of cardiovascular disease in the multiple risk factor intervention trial. Arterioscler Thromb Vasc Biol 17:1947-1953.
7. Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, Hess DL, Davis CE. 1998. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the atherosclerosis risk in communities (ARIC) study. Circulation 98:204-210.
8. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genet 10:111-113.
9. Harmon DL, Woodside JV, Yarnell JWG, McMaster D, Young IS, McCrum EE, Gey KF, Whitehead AS, Evans AE. 1996. The common "thermolabile" variant of methylenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. Q J Med 89:571-577.
10. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. 1996. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7-9.
11. Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, Eydoux P, Rosenblatt DS, Rozen R, Gravel RA. 1996. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cb1G complementation group of folate/cobalamin disorders. Hum Mol Genet 5:1867-1874.
12. Li YN, Gulati S, Baker PJ, Brody LC, Banerjee R, Kruger WD. 1996. Cloning, mapping and RNA analysis of the human methionine synthase gene. Hum Mol Genet 5:1851-1858.
13. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345:149-151.
14. Morrison K, Edwards YH, Lynch SA, Burn J, Hol F, Mariman E. 1997. Methionine synthase and neural tube defects. J Med Genet 34:958.
15. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230-236.
16. Omenn GS, Beresford SAA, Motulsky AG. 1998. Preventing coronary heart disease: B vitamins and homocysteine. Circulation 97:421-424.
17. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. 1995. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346:1395-1398.
18. Robinson K, Arheart K, Refsum H, Brattstrom L, Boers G, Ueland P, Rubba P, Palma-Reis R, Meleady R, Daly L, Witteman J, Graham I. 1998. Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation 97:437-443.
19. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH. 1993. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693-2698.
20. Statacorp (1997) Stata statistical analysis software: release 5.0. College Station TX: STATA Corporation.
21. Steegers-Theunissen RPM, Boers GHJ, Trijbels JMF, Finkelstein JD, Blom HJ, Thomas CMG, Borm GF, Wouters MGAJ, Eskes TKAB. 1994. Maternal hyperhomocysteinaemia: a risk factor for neural-tube defects? Metabolism 43:1475-1480.
22. van der Put NMJ, van der Molen EF, Kluijtmans LAJ, Heil SG, Trijbels JMF, Eskes TKAB, van Oppenraaij-Emmerzaal D, Banerjee R, Blom HJ. 1997. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. Q J Med 90:511-517.
23. van der Put NMJ, Gabreels F, Stevens EMB, Smeitink JAM, Trijbels JMF, Eskes TKAB, van den Heuvel LP, Blom HJ. 1998. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62:1044-1051.
24. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ. 1994. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 25:1924-1930.
25. 12 and folate. Am J Epidemiol 143:845-859.
26. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM. 1998. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med 158:862-867.
27. Welch GN, Loscalzo J. 1998. Homocysteine and atherothrombosis. New Engl J Med 338:1042-1050.
28. 6 status, MTHFR and hyperhomocysteinaemia. Q J Med 90:551-552